11:10 AM EDT, 04/17/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower Wednesday morning, falling 0.3% to 1,330.47 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Calliditas Therapeutics ( CALT ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which rose 4.6% and 3.1% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biopharmaceutical company DBV Technologies ( DBVT ) , which were up 3.4% and 0.03% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and semiconductor company Sequans Communications ( SQNS ) , which fell 3.7% and 2.5% respectively. They were followed by biopharmaceutical company argenx (ARGX) and biotech firm Biophytis ( BPTS ) , which dropped 2.4% and 2% respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group ( BHP ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which increased 3.7% and 3.5% respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and NuCana ( NCNA ) , which rose 2.7% and 2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which were down 3% and 2.2% respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals ( AVDL ) and biotech firm Trinity Biotech ( TRIB ) , which fell 2% and 1.5% respectively.